Please login to the form below
GERD
This page shows the latest GERD news and features for those working in and with pharma, biotech and healthcare.
Teva’s generic Nexium wins US approval
GERD is a serious form of gastroesophageal reflux, whereby a person's stomach contents come back into the oesophagus. ... This can cause acid indigestion, more commonly known as heartburn. Gastroesophageal reflux is definited as GERD when it occurs more
Latest news
-
AZ advances immuno-oncology ambitions
MedImmune - AZ's biologics division - will take full control of Definiens and its technologies, including its Cognition Network Technology, developed by Nobel Laureate Prof Gerd Binnig.
-
Takeda launches mobile app for heartburn patients
Food4GERD app includes symptom tracker and ingredient check functions. Takeda has launched a new mobile app to help patients with gastroesophageal reflux disease (GERD), or heartburn, manage their symptoms.
-
AstraZeneca launches Nexium YouTube channel
With more than one billion unique users visiting YouTube each month, the Nexium YouTube channel puts everything from background on GERD to information on cost savings for Nexium at patients' fingertips.". ... The AZPurpleZone channel includes:. 'Burning
-
Comment: AstraZeneca's branded approach to YouTube
AstraZeneca has launched a branded YouTube channel to promote its blockbuster gastroesophageal reflux disease (GERD) treatment Nexium (esomprazole). ... Although its first videos are Nexium adverts, AZ plans a regular, weekly series of “Burning
-
Omnicom to enhance German presence
Led by founders Dr Gerd Wirtz and Anett Coerper, has created a remarkable business which is both creative and innovative and unique in the healthcare agency space.
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Design considerations and best practices in clinical research
Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. ... Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. 5th January 2023.
-
Communicating health messages
Consider a 2010 study by Gerd Gigerenzer of the Harding Center for Risk Literacy.
-
The rise of chronic disease in BRIC markets
29 per cent report gastrointestinal conditions such as gastroesophageal reflux disease (GERD), IBS and diverticulitis.
-
Pharma deals during October 2012
As a further dimension to their relationship, the companies also announced a co-promotion agreement in the US for AZ's Nexium (esomeprazole magnesium) for gastroesophageal reflux disease (GERD). ... Many patients with IBS-C also suffer from GERD so this
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
GlycoVaxyn appoints Gerd Zettlmeissl as chairman
He will join the Swiss vaccines company in June. Swiss vaccines company GlycoVaxyn has appointed Gerd Zettlmeissl as chairman of the board of directors with effect from June, when he will ... Having chaired the board for more than seven years, I will
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW
Statins, such as atorvastatin, and the GERD drug omeprazole also saw significant gains.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Grace Communications
We’re an independent healthcare brand communications agency with a host of awards that speak to our success. Combining razor-sharp insights...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
